Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10213393 Composition and method for treating neurological disease

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11890261 Composition and method for treating neurological disease
0
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+423 characters)
Article

Patent abstract

The present disclosure is directed to methods of treating neurological disorders in a patient such as Parkinson's disease, drug-induced extrapyramidal reactions, and/or levodopa-induced dyskinesia comprising administering to the patient once daily in the morning a pharmaceutical composition comprising about 50 mg to about 400 mg of extended-release amantadine or a pharmaceutically acceptable salt thereof.

Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11833121 Composition and method for treating neurological disease
0
Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Ana Cristina Pastini0
Glenn A. Meyer0
Joaquina Faour0
Marcelo Fernando Befumo0
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Edits on 1 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 23 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 31 Jan, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jan, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10512617 Composition and method for treating neurological disease
Edits on 31 Jan, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jan, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10500172 Composition and method for treating neurological disease
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jan, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10500171 Composition and method for treating neurological disease
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jan, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10500170 Composition and method for treating neurological disease
Edits on 25 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 25 Jan, 2022
Edits made to:
Infobox (+7 properties)
‌

 US Patent 10213393 Composition and method for treating neurological disease

Infobox
Is a
Patent
Patent
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10213393
Date of patent
February 26, 2019
Patent application number
15898143
Date Filed
February 15, 2018
Patent primary examiner
‌
Umamaheswari Ramachandran

Find more entities like US Patent 10213393 Composition and method for treating neurological disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.